Makson Pharmaceuticals (India) Private Limited, a active private limited company, was established on 05 June 1986 in Wadhwancity, Gujarat, India. Engaging in bakery & confectionery products within the manufacturing sector, it holds CIN: U24231GJ1986PTC008718. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.84 M.
It upholds a compliant status. Employing 75 professional, Its leadership includes Kalpesh Dhanjibhai Makasana (Director), Dhanjibhai Anandjibhai Makasana (Director). Past directors included Kundanben Dhanjibhai Makasana. It holds ₹157.50 Cr open charges and ₹1.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 195, Rajkot Highway,, Surendranagar, Wadhwancity, Gujarat, 363020.
U24231GJ1986PTC008718
008718
05 June 1986
₹1.00 M
₹0.84 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Makson Pharmaceuticals (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kalpesh Dhanjibhai Makasana | Director | 11 Sep 2000 | Current |
| Dhanjibhai Anandjibhai Makasana | Director | 04 Sep 2000 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Jan 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Makson Pharmaceuticals (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 16.6% increase. The company also saw a substantial fall in profitability, with a 21.17% decrease in profit. The company's net worth Soared by an impressive increase of 15.55%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Makson Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,574,999,991.00
₹10,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Feb 2023 | Citi Bank N.A. | ₹35.00 Cr | Open |
| 04 May 2022 | Citi Bank N.A. | ₹24.00 Cr | Open |
| 28 Feb 2021 | Axis Bank Limited | ₹19.00 Cr | Open |
| 05 Feb 2021 | Citi Bank N.A. | ₹10.00 Cr | Open |
| 05 Feb 2021 | Citi Bank N.A. | ₹36.00 Cr | Open |
Explore comprehensive loan charge details -
Makson Pharmaceuticals (India) has a workforce of 75 employees as of Feb 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Makson Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Makson Pharmaceuticals (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Makson Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Makson Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.
Progress on A charge with Citi Bank N.A. amounted to Rs. 350.00 M with Charge ID 100684175 was registered on 01 Feb 2023. was documented.
A charge with Citi Bank N.A. of Rs. 240.00 M registered on 04 May 2022 with Charge ID 100579920 was modified on 01 Feb 2023. was recorded as a recent event.
Progress on A charge with Citi Bank N.A. of Rs. 100.00 M registered on 05 Feb 2021 with Charge ID 100411018 was modified on 01 Feb 2023. was documented.
Progress on A charge with Citi Bank N.A. of Rs. 360.00 M registered on 05 Feb 2021 with Charge ID 100411013 was modified on 01 Feb 2023. was documented.
The CIN of Makson Pharmaceuticals (India) Private Limited is U24231GJ1986PTC008718.
Makson Pharmaceuticals (India) Private Limited is headquartered at 195, Rajkot Highway,, Surendranagar, Wadhwancity, Gujarat, 363020.
Makson Pharmaceuticals (India) Private Limited was incorporated on 05 June 1986.
The current directors of Makson Pharmaceuticals (India) Private Limited are
The primary industry of Makson Pharmaceuticals (India) Private Limited is Manufacturing.
Makson Pharmaceuticals (India) Private Limited is unlisted.
The authorized capital of Makson Pharmaceuticals (India) Private Limited is ₹1.00 M, and the paid-up capital is ₹0.84 M.
The compliance status of Makson Pharmaceuticals (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX